RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis.

Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis.

Add to Collection
2022 Apr Systematic Review and Meta Analysis D Dutta, R Mohindra, V Surana, M Sharma - Diabetes & Metabolic …, 2022 - Elsevier

Full Author : ['Dutta, Deep', 'Mohindra, Ritin', 'Surana, Vineet', 'Sharma, Meha']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section2, Section4
Journal Year : 2022

BACKGROUND & AIMS: Pooled systematic analysis of safety and efficacy data of trelagliptin in type-2 diabetes (T2DM) is lacking. We undertook this meta-analysis to address this issue. METHODS: Electronic databases were searched for RCTs involving people wi..... Read More

Keywords : ['weekly inhibitor trelagliptin', 'safety', 'metaanalysis', 'efficacy', 'diabete']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1871402122000832